Related Experiment Video
Updated: Dec 3, 2025
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
13.0K
[Pharmacogenetic testing in acute and chronic pain: a preliminary study]
Panella Lorenzo1, Laura Volonté1, Nicola Poloni2
1Dipartimento di Riabilitazione, ASST Gaetano Pini-CTO, Via Isocrate 19, 20122 Milano (MI), Italia.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|October 29, 2020
Summary
Pharmacogenetic testing (PGT) shows potential for personalizing pain management. However, this preliminary study found partial discordance between PGT results and clinical outcomes in 5 patients, suggesting further research is needed.
Area of Science:
- Pharmacology
- Genetics
- Pain Management
Background:
- Pain significantly impacts quality of life and healthcare costs.
- Personalized medicine necessitates understanding individual drug responses.
- Pharmacogenetic testing (PGT) may optimize analgesic therapy.
Purpose of the Study:
- To compare clinical responses to analgesics with PGT results.
- To evaluate PGT's utility in patients with persistent pain.
Main Methods:
- A preliminary study involving 5 patients with acute and chronic pain.
- Comparison of genetic pharmacogenetic test results with clinical practice outcomes.
- Analysis of drug effectiveness and tolerability based on genetic profiles.
Main Results:
- 2 out of 5 genetic reports fully matched clinical findings.
- 3 out of 5 genetic reports showed partial discrepancies in drug tolerability and effectiveness.
- Pharmacogenetic testing results were not entirely concordant with clinical observations.
Conclusions:
- Further research is warranted to validate PGT in clinical pain management.
- Additional studies are needed to fully integrate PGT into clinical practice.
- The study highlights the need for more data on PGT's real-world application in pain therapy.
